Euan Thomson, president and CEO of Accuray Inc., on how his company managed to fare well despite the capital expenditure market's downturn, its distribution and R&D deal with Siemens and why healthcare reform could have a big upside for Accuray.
Accuray Inc. (NSDQ:ARAY) has a tough row to hoe: Cultivate a market that crosses medical specialty lines for a product that costs millions. The Sunnyvale, Calif.-based company's CyberKnife system is a pioneering device in radiosurgery, using precisely targeted, massive doses of X-ray radiation to non-invasively destroy tumors.
Founded in the 1990, Accuray's device was based on an idea developed by a team of physicians at Stanford University, led by Dr. John Adler, in the late 1980s. Since its founding the company has seen its share of ups and downs, not least...
Rob Lyles, who heads up Cook Medical's peripheral intervention business, on the company's origins in a two-bedroom apartment, the impact of gift bans on the medical device industry and developments in treating diseased blood vessels in the legs.
Cook Medical Group and Boston Scientific Corp. (NYSE:BSX) both got their start with catheter-based devices, but the medical device giants' similarities don't stop there. As Boston Scientific founder John Abele told MassDevice last month, his firm got its start in an unlikely place: the basement of a Catholic Church in Belmont, Mass.
Cook, the world's largest privately held medical device maker, had similarly humble origins. Founders Bill and Gayle Cook started their company out of one of the two bedrooms of their Bloomington, Ind., apartment in 1963. Rob Lyles, vice president and global leader of Cook Medical’s...
Abiomed president and CEO Michael Minogue on his company's Impella heart pump and its prospects for gaining a larger share of the cardiac assist market.
Abiomed Inc. (NSDQ:ABMD) makes cardiac assist devices powerful enough to pump more than a gallon of blood through the heart each minute and small enough to be placed inside the heart via catheter. It's a highly specialized, highly competitive market that's difficult to break into.
At an investors meeting in Boston last week, the company sought to deliver the message that its devices offer a less invasive option than ventricular assist devices and don't need to be combined with inotropic drugs as is often the case with intra-aortic balloon pumps. It's been two years since Abiomed won 510(k) clearance from the Food & Drug...
MassDevice talks to LifeImage president and CEO Hamid Tabatabaie about his company's e-sharing application for medical imaging.
If you’ve ever had a CT scan, X-ray or MRI, you were likely given a CD to tote around in case you wanted a second opinion. That’s because there isn’t a universal network or database for medical image files, even in an industry that demands standardization.
Hamid Tabatabaie and Amy Vreeland founded a company that aspires to solve this problem, which has existed ever since the first X-ray was digitized. Their company, LifeImage, lets patients, physicians and institutions search, share and access medical imaging records across different networks. LifeImage, which works with storage giant EMC (NYSE:EMC) for its cloud-...
Boston Scientific Corp. co-founder John Abele, in the second installment of a lengthy interview, on the early days with Peter Nicholas, his take on demands for increased transparency and his frustration with some of the company's recent low points.
Boston Scientific Corp. (NYSE:BSX) co-founder John Abele told us about the origins of the medical device giant in the first installment of a lengthy chat with MassDevice, detailing its start in the basement of a famed Czech mystic's lab in a Catholic church rectory.
In the second installment, Abele touches on how he and co-founder Peter Nicholas engineered the Boston Scientific's launch, how his involvement with the Natick, Mass.-based company evolved over the years and how being a "cheap son of a bitch" helped drive creativity and innovation in the early days.
Abele also gave us his take on the...
Boston Scientific Corp. co-founder John Abele, in the first installment of a lengthy interview, on the company's origins in the basement of a church rectory, its connection to a famous Czech mystic and how it overcame doctors' early skepticism about its catheter-based technology.
There aren't many multi-billion-dollar companies that can say they got their start in the basement of a Catholic church rectory. Still fewer can claim a connection to a famous Czech mystic credited with pioneering research into human consciousness (and, not incidentally, with inventing the steerable catheter).
But according to co-founder John Abele, Boston Scientific Corp. (NYSE:BSX) can. The Natick, Mass.-based medical device maker got its start with the steerable catheter invented by Itzhak Bentov, leveraging the platform into a family of catheter-based products that changed the way medicine is practiced.
In a lengthy interview...